Recombinant CEACAM5 (Labetuzumab Biosimilar) antibody

Catalog No. ABIN7093054

The Humanized Monoclonal anti-CEACAM5 (Labetuzumab Biosimilar) antibody is suitable to detect CEACAM5 (Labetuzumab Biosimilar) in samples from Human. It has been validated for ELISA.

Quick Overview for Recombinant CEACAM5 (Labetuzumab Biosimilar) antibody (ABIN7093054)

Target: CEACAM5 (Labetuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This CEACAM5 (Labetuzumab Biosimilar) antibody is un-conjugated

Application: ELISA

Grade: Research Grade

Product Details anti-CEACAM5 (Labetuzumab Biosimilar) Antibody

Purpose: Anti-CEACAM5 (labetuzumab biosimilar) mAb

Characteristics: IMMU-130, hMN-14-SN-38, hMN-14-SN-38 ADC, hMN14-CL-SN-38, hMN14-SN-38

Purification: Purified from cell culture supernatant by affinity chromatography

Isotype: IgG1

Application Details

Application Notes: ELISA 1:5000-10000

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for CEACAM5 (Labetuzumab Biosimilar)

Target: CEACAM5 (Labetuzumab Biosimilar)

Target Type: Biosimilar

Background: Synonyms: CEACAM-5,CD66e,CEA,Meconium antigen 100

Gene ID: 1048

UniProt: P06731